Tuberculosis Co-Infection Is Common in Patients Requiring Hospitalization for COVID-19 in Belarus: Mixed-Methods Study
Authors:
- Yuliia SeredaYSYuliia Sereda
- Oleksandr KorotychOKOleksandr Korotych
- Dzmitry KlimukDKDzmitry Klimuk
- Dzmitry ZhurkinDZDzmitry Zhurkin
- Varvara SolodovnikovaVSVarvara Solodovnikova
- Malgorzata GrzemskaMGMalgorzata Grzemska
- Viatcheslav GrankovVGViatcheslav Grankov
- Hennadz HurevichHHHennadz Hurevich
- Askar YedilbayevAskar Yedilbayev
- Alena SkrahinaASAlena Skrahina
Open Access
- 5 April 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (7) , 4370
Abstract
A significant drop in tuberculosis (TB) case-finding has been widely reported during the period of the COVID-19 pandemic. To address a decrease in TB notification, Belarus introduced laboratory TB testing in patients with the laboratory-confirmed coronavirus disease 2019 (COVID-19). We conducted a secondary analysis of health records among 844 patients with laboratory-confirmed COVID-19 diagnosis who were admitted to repurposed departments at TB hospitals and who were tested by Xpert MTB/RIF (Cepheid Inc., Sunnyvale, CA, USA) in five Belarus regions between April and October 2021. Quantitative analysis followed by 13 individual interviews with health managers, physicians, and nurses participating in the intervention. Most patients were male (64%) and mean age was 43.5 ± 16 years. One in twenty (n = 47, 5.6%) patients were co-infected with active pulmonary TB, and over one-third of them (n = 18) had rifampicin resistance. In-hospital mortality was comparable in patients with and without TB co-infection (2.1% and 2.3% respectively, p > 0.99). Laboratory TB testing among patients with COVID-19 at repurposed departments of TB hospitals is feasible in Belarus and may improve TB case-finding.Keywords
This publication has 15 references indexed in Scilit:
- Impact of COVID‐19 in patients with concurrent co‐infections: A systematic review and meta‐analysesJournal of Medical Virology, 2020
- Multidisciplinary consensus on sputum induction biosafety during the COVID‐19 pandemicAllergy, 2020
- COVID-19 -Tuberculosis interactions: When dark forces collideIndian Journal of Tuberculosis, 2020
- Systematic evaluation of transcriptomic disease risk and diagnostic biomarker overlap between COVID-19 and tuberculosis: a patient-level meta-analysismedRxiv, 2020
- Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditionsPLOS ONE, 2020
- The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysiseClinicalMedicine, 2020
- Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19Infectious Diseases, 2020
- Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020medRxiv, 2020
- Differential Recognition of Mycobacterium tuberculosis –Specific Epitopes as a Function of Tuberculosis Disease HistoryAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Virological and Immunological Impact of Tuberculosis on Human Immunodeficiency Virus Type 1 DiseaseThe Journal of Infectious Diseases, 2003